237 studies found for:    "cyclic neutropenia" OR "Neutropenia"
Show Display Options
Rank Status Study
21 Completed
Has Results
Observational Non-Interventional Study Of Febrile Neutropenia Patients To Evaluate Antibacterial Therapeutical Options
Condition: Febrile Neutropenia
Intervention: Drug: Antibacterial agent for the treatment of febrile neutropenia
22 Completed Meropenem Versus Meropenem Plus Glycopeptide in Patients With Febrile Neutropenia After Allogenic Blood Stem Cell Transplantation
Conditions: Allogenic Blood Stem Cell Transplantation;   Febrile Neutropenia
Interventions: Drug: Meropenem;   Drug: Vancomycin;   Drug: Teicoplanin
23 Completed Caspofungin Acetate in Treating Children With Fever and Neutropenia
Conditions: Fever, Sweats, and Hot Flashes;   Infection;   Kidney Cancer;   Leukemia;   Lymphoma;   Neuroblastoma;   Neutropenia;   Sarcoma
Intervention: Drug: caspofungin acetate
24 Terminated Study of Ezatiostat (Telintra Tablets) for Treatment of Severe Chronic Neutropenia
Condition: Severe Chronic Neutropenia
Intervention: Drug: Ezatiostat Hydrochloride
25 Withdrawn Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Neutropenia
Conditions: Fever, Sweats, and Hot Flashes;   Infection;   Leukemia;   Lymphoma;   Myelodysplastic Syndromes;   Neutropenia;   Unspecified Childhood Solid Tumor, Protocol Specific
Intervention: Biological: recombinant human mannose-binding lectin
26 Unknown  Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia
Conditions: Fever, Sweats, and Hot Flashes;   Infection;   Leukemia;   Lymphoma;   Neutropenia;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: cefepime hydrochloride;   Drug: levofloxacin
27 Completed Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia
Conditions: Breast Cancer;   Neutropenia
Intervention: Drug: AVI-014 versus Filgrastim
28 Recruiting A comparatiVe Study on Efficacy and Safety of Lipegfilgrastim in Comparison to Pegfilgrastim in Elderly Patients With Aggressive B Cell Non-HOdgkin Lymphomas at hIgh Risk for R-CHOP-21-inDuced Neutropenia
Condition: Aggressive B Cell Non-Hodgkin Lymphomas at High Risk for R-CHOP-21-induced Neutropenia
Interventions: Drug: lipegfilgrastim;   Drug: pegfilgrastim
29 Withdrawn A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropenia
Conditions: Cancer;   Hematologic Diseases;   Fever;   Neutropenia
Intervention: Drug: Intravenous recombinant human mannose binding lectin
30 Terminated Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or Refractory Non-Hodgkin's Lymphoma
Conditions: Lymphoma;   Neutropenia
Interventions: Biological: epoetin alfa;   Biological: filgrastim;   Biological: recombinant flt3 ligand;   Biological: recombinant interleukin-3;   Biological: sargramostim;   Procedure: in vitro-treated peripheral blood stem cell transplantation
31 Completed Study Investigating How Physicians Assess the Risk of Patients Developing Febrile Neutropenia During Chemotherapy.
Condition: Chemotherapy-induced Febrile Neutropenia
Intervention:
32 Terminated Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribavirin
Conditions: Anemia;   Neutropenia;   Hepatitis C Virus;   HIV Infections
Intervention: Drug: erythropoietin, GCSF
33 Completed G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy
Conditions: Chemotherapeutic Agent Toxicity;   Neutropenia;   Unspecified Adult Solid Tumor, Protocol Specific
Intervention: Biological: filgrastim
34 Completed Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Cancer Patients
Condition: Chemotherapy-induced Neutropenia
Interventions: Biological: empegfilrastim;   Biological: filgrastim
35 Active, not recruiting Study of the Efficacy and Safety of Empegfilgrastim for Neutropenia Prophylaxis in Cancer Patients
Condition: Chemotherapy-induced Neutropenia
Interventions: Biological: empegfilrastim 6 mg;   Biological: filgrastim;   Biological: Placebo №1;   Biological: Placebo №2;   Biological: empegfilrastim 7,5 mg
36 Recruiting A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Cancer.
Conditions: Stage III Colorectal Cancer;   Neutropenia
Interventions: Drug: MB-6;   Drug: Placebo
37 Unknown  A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy
Conditions: Breast Cancer;   Chemotherapy;   Neutropenia
Intervention: Other: EW02
38 Terminated Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting
Conditions: Fever;   Neutropenia;   Cancer
Interventions: Drug: ciprofloxacin and amoxicillin;   Procedure: Outpatient management;   Drug: i.v. antibiotics;   Procedure: inpatient management
39 Completed GCPGC in Chemotherapy-induced Neutropenia
Condition: Chemotherapy Induced Neutropenia
Interventions: Biological: GCPGC 3.6mg;   Biological: GCPGC 6mg;   Biological: Neulasta (pegfilgrastim) 6mg
40 Completed Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RING Study)
Conditions: Neutropenia;   Infection
Interventions: Drug: Standard antimicrobial therapy;   Biological: Granulocyte transfusions;   Drug: G-CFS/dexamethasone;   Device: Apheresis machine

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years